BlackRock
IDIX

BlackRock’s IDENIX PHARMACEUTICALS INC IDIX Stock Holding History

BlackRock’s Portfolio IDIX Stock Details IDIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-2,695
Closed -$65K – 3219
2014
Q2 		$65K Sell
2,695
-213
-7% -$2.22K ﹤0.01% 1826
2014
Q1 		$18K Buy
2,908
+250
+9% +$1.74K ﹤0.01% 2427
2013
Q4 		$16K Hold
2,658
– – ﹤0.01% 2483
2013
Q3 		$14K Hold
2,658
– – ﹤0.01% 2474
2013
Q2 		$10K Buy
+2,658
New +$10.9K ﹤0.01% 2677

BlackRock's IDIX Position: Q3 2014 in Review

BlackRock sold out of IDENIX PHARMACEUTICALS INC (IDIX) in Q3 2014, closing a stake of 2,695 shares — an estimated $65K sold.

BlackRock first reported a position in IDIX in Q2 2013 and held it in 5 quarters. The position peaked at $65K in Q2 2014. 0 funds tracked by Wall St. Rank hold IDIX as of Q3 2014.

  • BlackRock reported no remaining IDENIX PHARMACEUTICALS INC position as of Q3 2014 after selling out during the quarter.
  • BlackRock sold 2,695 IDENIX PHARMACEUTICALS INC shares in Q3 2014, an estimated $65K.
  • BlackRock first reported a position in IDENIX PHARMACEUTICALS INC in Q2 2013 and held it in 5 quarters.
  • BlackRock's IDENIX PHARMACEUTICALS INC position peaked at $65K in Q2 2014.
  • 0 funds tracked by Wall St. Rank held IDENIX PHARMACEUTICALS INC as of Q3 2014.

Based on BlackRock's 13F filing for Q3 2014, filed 29 Oct 2014.